<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01197092</url>
  </required_header>
  <id_info>
    <org_study_id>CS-101-01</org_study_id>
    <nct_id>NCT01197092</nct_id>
  </id_info>
  <brief_title>The Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitus Type II</brief_title>
  <official_title>A Study Evaluating the Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitus Type II</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Center for Integrative Medicine, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Center for Integrative Medicine, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A treatment with the concept of mitochondrial medication developed by Dr Heinrich Kremer can
      demonstrably improve and successfully treat actual parameters of Diabetes Mellitus II as well
      as its risk factors.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">January 2011</completion_date>
  <primary_completion_date type="Anticipated">January 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1c Test (Glycated hemoglobin)</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood count</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrolytes</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver, pancreatic and kidney retention values</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipids: Cholesterol,Triglycerides</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxyd LDL (low-density lipoprotein cholesterol)</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Free lipids fasting</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipoprotein A</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fibrinogen</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRP (C Reactive protein)</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDH-Isoenzymes (Lactate dehydrogenase)</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Homocysteins</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutrient IgGs Panels (BiomedicalScreen)</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin, Adiponectin, Leptin</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Potassium, selene, magnesium, zinc in whole blood</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SHbG, full-testosterone (Androgen-Index)</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PlasminInhibitor I</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamins B1,B2,B6,B 12, Vitamin D</measure>
    <time_frame>4 month average</time_frame>
    <description>Laboratory test</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Diabetes Mellitus, Type II</condition>
  <arm_group>
    <arm_group_label>Verum</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Mitochondrial preparations</intervention_name>
    <description>Oral therapy with mitochondrial preparations based on recipes of Dr Kremer and the Tisso company:
ProEMSan (large intestinal symbionts with 31 strains of bacteria) Pro Basan (small intestinal symbionts) ProSirtusan (Polyphenol-mix and vitamins) ProVita D3 (Vitamin D3 supplement) ProOmega (Omega 3-fatty acid preparation) ProCarnitin (Carnitine-preparation) ProSango Vital (trace element preparation)</description>
    <arm_group_label>Verum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Infusion therapy</intervention_name>
    <description>Infusion therapy in the form of a complex mix: 500ml-solution with trace elements, amino acids and antioxidants.</description>
    <arm_group_label>Verum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Webermedical device</intervention_name>
    <description>Intravenous-Blood-Laser-Therapy: the Webermedical device will be used</description>
    <arm_group_label>Verum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nutritional therapy</intervention_name>
    <description>Nutritional therapy based on IgG-blood results. Significant antibody-formation against foodstuffs will be ascertained (in foodstuffs evaluated through the BioMedicalScreen), will be taken out of the diet - the background being the additional lowering of risk potential of those antibodies causing the so called &quot;silent inflammation&quot; (sub-clinical inflammation) -ultimately an anti-inflammatory diet will be given in the protocol. The following have special focus: gluten, cow's milk, fish, meat, nuts.</description>
    <arm_group_label>Verum</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men and women between the ages of 18 and 60

          -  recently diagnosed Diabetes Type II (within the last 12 months)

        Exclusion Criteria:

          -  no orally-taken medication up to present

          -  no insulin therapy

          -  no diseases resulting from diabetes like Nephropathy, Neuropathy, Angiopathy or
             Retinopathy

          -  fasting blood sugar values in the morning under 200mmol

          -  sufficient production of insulin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rainer Mutschler, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_contact>
    <last_name>Rainer Mutschler, MD</last_name>
    <phone>06232 - 28 90 88 0</phone>
    <email>mutschler@cfi-speyer.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>CFI Centrum f√ºr Integrative Medizin</name>
      <address>
        <city>Speyer</city>
        <zip>D-67346</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rainer Mutschler, MD</last_name>
      <phone>06232 - 28 90 88 0</phone>
      <email>mutschler@cfi-speyer.de</email>
    </contact>
    <investigator>
      <last_name>Rainer Mutschler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2010</study_first_submitted>
  <study_first_submitted_qc>September 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2010</study_first_posted>
  <last_update_submitted>November 15, 2010</last_update_submitted>
  <last_update_submitted_qc>November 15, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 16, 2010</last_update_posted>
  <responsible_party>
    <name_title>Rainer Mutschler</name_title>
    <organization>Center for Integrative Medicine</organization>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

